2026 Update: Henry Meds' "$179/Month" Doesn't Apply to Tirzepatide
Henry Meds' widely advertised low headline rate applies to other products in their lineup — not compounded tirzepatide specifically. Real tirzepatide pricing at Henry Meds runs approximately $297–$299/month as an introductory rate, stepping up to approximately $429–$549/month at maintenance for the injectable format (or ~$349/month for oral tablets, billed quarterly). This is a materially different — and often higher — cost than the headline rate suggests, and changes the comparison against flat-rate platforms considerably.
Henry Meds' Real Tirzepatide Pricing vs Flat-Rate Platforms
Henry Meds and flat-rate telehealth platforms like Luma Health offer the same medication — compounded tirzepatide using the same active pharmaceutical molecule at equivalent pharmacological doses. The meaningful difference is the pricing structure, and at Henry Meds specifically, that structure escalates significantly from introductory to maintenance dosing.
~$297–$549/mo
- ~$297–$299/mo introductory rate
- ~$429–$549/mo at maintenance doses
- ~$349/mo for oral tablets (billed quarterly)
- Pharmacy not prominently named publicly
- Advertised "$179/month" headline does not apply to tirzepatide
$297/mo Flat — Every Dose
- $297/mo flat — introductory through maintenance, no step-up
- No annual commitment — cancel anytime
- VialsRX (TX #35264) publicly named and verifiable
- Wasef Health, PC clinical oversight
- At maintenance doses, comparable to or less than Henry Meds' real rate
Tirzepatide Clinical Evidence — What the Research Shows
Annual Cost Math: Henry Meds vs Luma Health Tirzepatide
Since most patients spend the majority of their treatment time at maintenance dose (not the introductory tier), the annual comparison favors flat-rate pricing for most long-term patients. Verify Henry Meds' current specific rate directly at henrymeds.com, as pricing structures continue to evolve.
Full Comparison: Henry Meds vs Luma Health for Tirzepatide
| Factor | Henry Meds | Luma Health |
|---|---|---|
| Introductory rate | ~$297–$299/mo | $297/mo |
| Maintenance rate | ~$429–$549/mo | $297/mo (unchanged) |
| Pharmacy named | Not prominently | ✓ VialsRX TX#35264 |
| Commitment | Verify directly | None — cancel anytime |
| Insurance required | No | No |
| Best for | Patients who confirm current rates fit their budget | Patients wanting price certainty from day one through maintenance |
Who Should Choose Henry Meds vs Luma Health for Tirzepatide
Henry Meds May Work If You...
- Confirm current pricing directly and it fits your budget at your expected dose
- Are comfortable with a rate that increases as your dose escalates
- Also want testosterone, thyroid, or other hormone services alongside tirzepatide
★ Luma Health Wins If You...
- Want pharmacy independently verifiable before payment
- Want the same flat $297/mo rate whether you're starting or at maintenance
- Want no commitment and no rate surprises as your dose changes
- Want HRT / NAD+ alongside tirzepatide through a single provider
One price.
From day one through maintenance.
$297/mo tirzepatide flat. VialsRX (TX #35264). No contracts.
Start With Luma Health →Frequently Asked Questions
Not at maintenance doses. Henry Meds' widely advertised "$179/month" doesn't apply to tirzepatide — real pricing runs ~$297–$299/month introductory, stepping up to ~$429–$549/month at maintenance. Luma Health is $297/month flat at every dose. Since most patients spend most of their treatment at maintenance, Luma Health is typically comparable to or less expensive over time.
Yes — pharmacologically. Both prescribe compounded tirzepatide using the same active pharmaceutical ingredient at equivalent doses. SURMOUNT-1 data (22.5% average weight loss at 72 weeks at 15 mg) applies to the molecule regardless of which licensed 503A pharmacy prepared it.
Henry Meds uses a dose-tiered pricing structure for tirzepatide, where the introductory rate applies at lower starting doses and the price steps up as you titrate to maintenance. This is different from flat-rate platforms like Luma Health, where the price is the same regardless of dose.
Tirzepatide produces greater average weight loss than semaglutide at comparable doses. SURMOUNT-1 showed ~22.5% weight reduction at 72 weeks for tirzepatide 15 mg vs ~14.9% for semaglutide 2.4 mg in STEP 1. The difference reflects tirzepatide's dual GIP/GLP-1 mechanism. At Luma Health: sema $197/mo flat vs tirz $297/mo flat.
Yes. Start Luma Health's intake with your current tirzepatide dose. Wasef Health, PC prescribes at your current dose — no re-titration. Wait for VialsRX shipping confirmation before canceling Henry Meds. The pharmacological transition is seamless — same active molecule, same weekly schedule.
References
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed 35658024
- Frías JP, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). N Engl J Med. 2021;385(6):503–515. PubMed 34170647
- Aronne LJ, et al. Continued Treatment with Tirzepatide for Maintenance of Weight Reduction (SURMOUNT-4). JAMA. 2024;331(1):38–48. PubMed 38078870
- FDA. Zepbound (tirzepatide) Prescribing Information. FDA.gov
- FDA. Human Drug Compounding — Section 503A. FDA.gov
- Texas State Board of Pharmacy. License Verification. pharmacy.texas.gov